Over 100 years serving the Lord home and around the world
First Baptist Church
We are a church who's members come from many nations of origin to worship together!

The FDA appears to think so.

Animal research using oil from ‘improved’ rapeseeds possess challenged medical claims designed for canola oil as well as undermined what has come to be traditional thinking on the link between types of fats eaten and cardiovascular disease. Sally Fallon and Mary G. Enig, Ph.D. Are North America’s leading professionals about fats and oils. They have created extensively about them and several of their works are available at the Weston A. Price Foundation website. The following is a summary of the research findings they consider relevant to the use of canola oil: A report published in 1978 in holland investigated whether oil from hybridized rapeseed plants caused center lesions in test animals. The researchers noted that in previously studies, animals fed the high erucic-acid rapeseed oil showed growth retardation and undesirable adjustments in various organs, the heart especially, spurring development of hybridized variations of the seed.Using a community-structured registry, Dr. Kurlansky and co-workers examined data on all individuals going through PCI or CABG for coronary artery disease February 1-July 31, 2004, who also got follow-up data by 2011. Of the 1,082 sufferers who met the criteria, the researchers were able to compare 240 well-matched individuals from each treatment group. Unlike a lot of other studies that focus on select groups of sufferers who receive unique therapies, our outcomes reflect a 'real world' picture of modern medical practice and so are broadly applicable to the general population of diabetic patients with serious coronary artery disease, said Dr. Kurlansky. Results demonstrated that mortality was more prevalent in sufferers who received PCI than those that underwent CABG.